medmix AG (MEDX)

Currency in CHF
8.78
-0.04(-0.45%)
Closed·
High dividend Yield
MEDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.618.94
52 wk Range
8.1813.02
Key Statistics
Bid/Ask
8.85 / 9.58
Prev. Close
8.78
Open
8.8
Day's Range
8.61-8.94
52 wk Range
8.18-13.02
Volume
79.6K
Average Volume (3m)
74.99K
1-Year Change
-16.6983%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.97
Upside
+81.85%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

medmix AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for prosthetics, restoratives, anesthetics, and aesthetics; the pen and auto injectors, which are used in fertility and growth hormone treatments, treatment of diabetes, osteoporosis, and other diseases; and the delivery and mixing devices, which are used by tissue banks and medical device OEMs. It also produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in construction, transportation, electronics, infrastructure, and general industrial sectors; and micro-brushes and applicators for eyes, eyelashes, lips, and facial make-up. The company offers its products under the Mixpac, Transcodent, Qiaoyi, Cox, MK, Medmix, Haselmeier, and Geka brands. medmix AG was founded in 1922 and is based in Baar, Switzerland.

medmix AG Earnings Call Summary for H2/2025

  • Medmix revenue fell 7.4% to CHF 448M in 2025, pressured by FX headwinds and organic decline; stock dropped 19% post-earnings.
  • Adjusted EBITDA margin reached 20%, exceeding expectations; gross profit margin expanded to 36.1% from 33.0% year-over-year.
  • EBIT surged 76.7% to CHF 22.8M; Growth and Efficiency program successfully drove profitability despite revenue challenges.
  • Healthcare segment increased contribution to 38% of revenue, while Consumer and Industrial segments declined amid market headwinds.
  • CEO emphasized focus on margin enhancement and balance sheet strength; FX volatility and segment declines remain key risks ahead.
Last Updated: 26/02/2026, 10:40
Read Full Transcript

Compare MEDX to Peers and Sector

Metrics to compare
MEDX
Peers
Sector
Relationship
P/E Ratio
55.8x15.6x−0.5x
PEG Ratio
0.31−0.140.00
Price/Book
0.8x1.7x2.6x
Price / LTM Sales
0.8x1.8x3.2x
Upside (Analyst Target)
82.2%26.5%49.3%
Fair Value Upside
Unlock4.4%6.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.97
(+81.85% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy16.00+82.23%18.00Maintain10/03/2026
Stifel
Buy14.50+65.15%-New Coverage25/11/2025
UBS
Buy18.00+105.01%25.00Maintain31/03/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.15%
Dividend Yield
5.69%
Industry Median 1.74%
Annualised payout
0.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 26, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
222.60M / --
EPS Revisions
Last 90 days

medmix (MEDX) Income Statement & Profits

People Also Watch

20.1
VETN
-0.99%
270.50
SWTQ
+2.46%
16.12
MIKN
-0.98%
14.9600
ILM1k
-4.35%
117.80
AUTON
+0.86%

FAQ

What Is the medmix (MEDX) Share Price Today?

The medmix stock price today is 8.78 CHF.

What Stock Exchange Does medmix (MEDX) Trade On?

medmix is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for medmix?

The stock symbol (also called a 'ticker') for medmix is "MEDX."

Does medmix Pay Dividends? What’s The Current MEDX Dividend Yield?

Yes, MEDX Pays Dividends to its Shareholders. The current medmix dividend yield is 5.69%.

What Is the Current medmix Market Cap?

As of today, medmix market cap is 357.11M CHF.

What Is medmix's (MEDX) Earnings Per Share (TTM)?

The medmix EPS is currently 0.15 (Trailing Twelve Months).

Is MEDX a Buy or Sell From a Technical Analyst Perspective?

Based on today's medmix moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has medmix Stock Split?

medmix has split 0 times. (See the MEDX stock split history page for full effective split date and price information.)

How Many Employees Does medmix Have?

medmix has 2667 employees.

What is the current trading status of medmix (MEDX)?

As of 12/03/2026, medmix (MEDX) is trading at a price of 8.78 CHF, with a previous close of 8.78 CHF. The stock has fluctuated within a day range of 8.61 CHF to 8.94 CHF, while its 52-week range spans from 8.18 CHF to 13.02 CHF.

What Is medmix (MEDX) Price Target According to Analysts?

The average 12-month price target for medmix is 15.97 CHF, with a high estimate of 16 CHF and a low estimate of 15.9 CHF. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +81.85% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.